Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN‐amplified retinoblastoma

A small, but unique subgroup of retinoblastoma has been identified with no detectable mutation in the retinoblastoma gene (RB1) and with high levels of MYCN gene amplification. This manuscript investigated alternate pathways of inactivating pRb, the encoded protein in these tumors. We analyzed the mutation status of the RB1 gene and MYCN copy number in a series of 245 unilateral retinoblastomas, and the phosphorylation status of pRb in a subset of five tumors using immunohistochemistry. There were 203 tumors with two mutations in RB1 (RB1−/−, 83%), 29 with one (RB1+/−, 12%) and 13 with no detectable mutations (RB1+/+, 5%). Eighteen tumors carried MYCN amplification between 29 and 110 copies: 12 had two (RB1−/−) or one RB1 (RB1+/−) mutations, while six had no mutations (RB1+/+). Immunohistochemical staining of tumor sections with antibodies against pRb and phosphorylated Rb (ppRb) displayed high levels of pRb and ppRb in both RB1+/+ and RB1+/− tumors with MYCN amplification compared to no expression of these proteins in a classic RB1−/−, MYCN‐low tumor. These results establish that high MYCN amplification can be present in retinoblastoma with or without coding sequence mutations in the RB1 gene. The functional state of pRb is inferred to be inactive due to phosphorylation of pRb in the MYCN‐amplified retinoblastoma without coding sequence mutations. This makes inactivation of RB1 by gene mutation or its protein product, pRb, by protein phosphorylation, a necessary condition for initiating retinoblastoma tumorigenesis, independent of MYCN amplification.

[1]  J. Osorio.  Cell cycle: Repurposing MYC and E2F in the absence of RB , 2015, Nature Reviews Molecular Cell Biology.

[2]  R. Machiraju,et al.  Redeployment of Myc and E2f1-3 drives Rb deficient cell cycles , 2015, Nature Cell Biology.

[3]  C. Shields,et al.  Enhanced Sensitivity for Detection of Low‐Level Germline Mosaic RB1 Mutations in Sporadic Retinoblastoma Cases Using Deep Semiconductor Sequencing , 2014, Human mutation.

[4]  R. Wilson,et al.  RB1 gene inactivation by chromothripsis in human retinoblastoma , 2014, Oncotarget.

[5]  C. Shields,et al.  High-risk retinoblastoma based on international classification of retinoblastoma: analysis of 519 enucleated eyes. , 2013, Ophthalmology.

[6]  W. Lam,et al.  Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies. , 2013, The Lancet. Oncology.

[7]  Greg L. Hura,et al.  Structures of inactive retinoblastoma protein reveal multiple mechanisms for cell cycle control. , 2012, Genes & development.

[8]  N. Dyson,et al.  Phosphorylation puts the pRb tumor suppressor into shape. , 2012, Genes & development.

[9]  J. Biegel,et al.  p16INK4A and p14ARF Tumor Suppressor Pathways Are Deregulated in Malignant Rhabdoid Tumors , 2011, Journal of neuropathology and experimental neurology.

[10]  Jeroen F. J. Laros,et al.  LOVD v.2.0: the next generation in gene variant databases , 2011, Human mutation.

[11]  C. Shields,et al.  Differential gene expression profile of retinoblastoma compared to normal retina , 2010, Molecular vision.

[12]  F. Westermann,et al.  Transcriptional repression of SKP2 is impaired in MYCN-amplified neuroblastoma. , 2010, Cancer research.

[13]  C. Shields,et al.  MOLECULAR KARYOTYPE OF SPORADIC UNILATERAL RETINOBLASTOMA TUMORS , 2009, Retina.

[14]  B. Gallie,et al.  Patterns of missplicing caused by RB1 gene mutations in patients with retinoblastoma and association with phenotypic expression , 2008, Human mutation.

[15]  J. Khan,et al.  High Skp2 Expression Characterizes High-Risk Neuroblastomas Independent of MYCN Status , 2007, Clinical Cancer Research.

[16]  T. Corson,et al.  One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma , 2007, Genes, chromosomes & cancer.

[17]  L. Desjardins,et al.  A deep intronic mutation in the RB1 gene leads to intronic sequence exonisation , 2007, European Journal of Human Genetics.

[18]  T. Jacks,et al.  Murine bilateral retinoblastoma exhibiting rapid‐onset, metastatic progression and N‐myc gene amplification , 2007, The EMBO journal.

[19]  A. Giordano,et al.  RB and cell cycle progression , 2006, Oncogene.

[20]  P. Lichter,et al.  Detection of chromosomal imbalances in retinoblastoma by matrix‐based comparative genomic hybridization , 2005, Genes, chromosomes & cancer.

[21]  C. Shields,et al.  Sensitive multistep clinical molecular screening of 180 unrelated individuals with retinoblastoma detects 36 novel mutations in the RB1 gene , 2005, Human mutation.

[22]  M. Kitagawa,et al.  Preferences for phosphorylation sites in the retinoblastoma protein of D-type cyclin-dependent kinases, Cdk4 and Cdk6, in vitro. , 2005, Journal of biochemistry.

[23]  Jean Y. J. Wang,et al.  Coordinated regulation of life and death by RB , 2003, Nature Reviews Cancer.

[24]  A. Moll,et al.  Comparative genomic hybridisation divides retinoblastomas into a high and a low level chromosomal instability group , 2003, Journal of clinical pathology.

[25]  Z. Onadim,et al.  High level amplification of N-MYC is not associated with adverse histology or outcome in primary retinoblastoma tumours , 2002, British Journal of Cancer.

[26]  B. Gallie,et al.  Minimal regions of chromosomal imbalance in retinoblastoma detected by comparative genomic hybridization. , 2001, Cancer genetics and cytogenetics.

[27]  H. Rehder,et al.  Marked differences in unilateral isolated retinoblastomas from young and older children studied by comparative genomic hybridization , 2001, Human Genetics.

[28]  J. Harbour,et al.  The Rb/E2F pathway: expanding roles and emerging paradigms. , 2000, Genes & development.

[29]  A. Aurias,et al.  Detection of chromosome imbalances in retinoblastoma by parallel karyotype and CGH analyses , 2000, Genes, chromosomes & cancer.

[30]  Wen-Hwa Lee,et al.  Expression and amplification of the N-myc gene in primary retinoblastoma , 1984, Nature.

[31]  A. Knudson.  Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[32]  T. Corson,et al.  The genomic landscape of retinoblastoma: a review , 2014, Clinical & experimental ophthalmology.

[33]  S. M. Rubin.  Deciphering the retinoblastoma protein phosphorylation code. , 2013, Trends in biochemical sciences.

[34]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.